Visienco is a Swiss life-science technology company making complex 3D biology more reproducible, scalable and data-driven.
Organoids and other 3D tissue models are transforming drug discovery, yet many workflows still rely on manual handling, subjective assessment and processes that are difficult to standardize. We are changing that.
Our first platform, the Orgadroid, combines precision robotics, imaging and AI-powered morphology analysis to automate the handling, quality control, selection and transfer of organoids and other complex 3D tissues. The result: faster, more consistent and traceable workflows, with valuable morphological data captured along the way.
Founded as a spin-off from CSEM, the Swiss Center for Electronics and Microtechnology, Visienco builds on years of research and patented technology. Today, we are bringing the Orgadroid to research and drug development laboratories in Europe and the United States.
Our ambition is to make 3D biology truly scalable — providing the automation and data infrastructure needed for the next generation of drug discovery and development.
Interested in joining Visienco? Contact us at jobs@visienco.ch.
